Title:
COMPOSITION CONTAINING β-GLYCYRRHETINIC ACID, AND ETHYLENEDIAMINE TETRAACETIC ACID AND/OR SALT THEREOF
Document Type and Number:
Japanese Patent JP2023094855
Kind Code:
A
Abstract:
To provide a composition that inhibits neutrophil collagenase activity.SOLUTION: An oral composition contains β-glycyrrhetinic acid, and ethylenediamine tetraacetic acid and/or a salt thereof. A total content of the ethylenediamine tetraacetic acid and/or the salt thereof is 0.15-5 pts.mass relative to 1 pt.mass of β-glycyrrhetinic acid.SELECTED DRAWING: None
Inventors:
URAKAWA RIKA
ARITA TAKUYA
ARITA TAKUYA
Application Number:
JP2021210410A
Publication Date:
July 06, 2023
Filing Date:
December 24, 2021
Export Citation:
Assignee:
SUNSTAR INC
International Classes:
A61K8/63; A61K8/44; A61K31/19; A61K31/198; A61P1/02; A61P43/00; A61Q11/00
Attorney, Agent or Firm:
Saegusa International Patent Office
Previous Patent: Composition containing β-glycyrrhetinic acid and zinc gluconate
Next Patent: Composition containing hinokitiol and zinc gluconate
Next Patent: Composition containing hinokitiol and zinc gluconate